Ledger.Open graph →
SEC Form D · filed May 22, 2015

PLASMATECH BIOPHARMACEUTICALS INC

Offering
$10.0M
Sold
$10.0M
Exemption
Rule 506(c)
Industry
Pharmaceuticals
Location
DALLAS, TX
Type
—

Rule 506(c): private placement that may advertise publicly; all investors must be verified accredited.

People & firms on this filing (17)

Mark J. Alvino · Dallas, TXDirectorJeffrey H. Davis · Dallas, TXDirectorStephen B. Thompson · Dallas, TXExecStephen B. Howell · Dallas, TXDirectorMichael J. Shea · Salem, ORExecWilliam S. Gray · Charlottesville, VADirectorJames M. Greene · Charlottesville, VADirectorSteven H. Rouhandeh · Dallas, TXExecMark J. Ahn · Dallas, TXDirectorTodd B. Widder · Dallas, TXDirectorScott Lennon · GRAND CAYMAN, Cayman IslandsDirectorRichard Hoge · DARIEN, CTDirectorCarrie L. Branovan · Pahoa, HIExecRussell C. Smith · Pahoa, HIDirectorSteven H. Rouhandeh · Dallas, TXExecMark J. Ahn · Dallas, TXDirectorTodd B. Widder · Dallas, TXDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗